BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25100046)

  • 1. Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline.
    Gankam Kengne F; Couturier BS; Soupart A; Decaux G
    Kidney Int; 2015 Feb; 87(2):323-31. PubMed ID: 25100046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hyponatremia: the role of lixivaptan.
    Liamis G; Filippatos TD; Elisaf MS
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):431-41. PubMed ID: 24766294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline prevents osmotic demyelination associated with aquaresis.
    Takagi H; Sugimura Y; Suzuki H; Iwama S; Izumida H; Fujisawa H; Ogawa K; Nakashima K; Ochiai H; Takeuchi S; Kiyota A; Suga H; Goto M; Banno R; Arima H; Oiso Y
    Kidney Int; 2014 Nov; 86(5):954-64. PubMed ID: 24759153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of dexamethasone on osmotic-induced demyelination in rats.
    Sugimura Y; Murase T; Takefuji S; Hayasaka S; Takagishi Y; Oiso Y; Murata Y
    Exp Neurol; 2005 Mar; 192(1):178-83. PubMed ID: 15698632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limits of brain tolerance to daily increments in serum sodium in chronically hyponatraemic rats treated with hypertonic saline or urea: advantages of urea.
    Soupart A; Stenuit A; Perier O; Decaux G
    Clin Sci (Lond); 1991 Jan; 80(1):77-84. PubMed ID: 1846795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering.
    Soupart A; Penninckx R; Crenier L; Stenuit A; Perier O; Decaux G
    Kidney Int; 1994 Jan; 45(1):193-200. PubMed ID: 8127009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid correction of hyponatraemia with urea may protect against brain damage in rats.
    Van Reeth O; Decaux G
    Clin Sci (Lond); 1989 Sep; 77(3):351-5. PubMed ID: 2805597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia.
    Baker EA; Tian Y; Adler S; Verbalis JG
    Exp Neurol; 2000 Oct; 165(2):221-30. PubMed ID: 10993682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertonic saline, isotonic saline, water restriction, long loops diuretics, urea or vaptans to treat hyponatremia.
    Decaux G; Gankam Kengne F
    Expert Rev Endocrinol Metab; 2020 May; 15(3):195-214. PubMed ID: 32401559
    [No Abstract]   [Full Text] [Related]  

  • 10. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats.
    Silver SM; Schroeder BM; Sterns RH; Rojiani AM
    J Neuropathol Exp Neurol; 2006 Jan; 65(1):37-44. PubMed ID: 16410747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rapid correction of hyponatremia on the blood-brain barrier of rats.
    Adler S; Verbalis JG; Williams D
    Brain Res; 1995 May; 679(1):135-43. PubMed ID: 7648255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of severe hyponatremia (<120mEq/l)].
    Decaux G
    Rev Med Brux; 2001 Oct; 22(5):413-9. PubMed ID: 11723783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of symptomatic hyponatremia.
    Decaux G; Soupart A
    Am J Med Sci; 2003 Jul; 326(1):25-30. PubMed ID: 12861122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytes are an early target in osmotic demyelination syndrome.
    Gankam Kengne F; Nicaise C; Soupart A; Boom A; Schiettecatte J; Pochet R; Brion JP; Decaux G
    J Am Soc Nephrol; 2011 Oct; 22(10):1834-45. PubMed ID: 21885671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hyponatremia: providing treatment and avoiding harm.
    Vaidya C; Ho W; Freda BJ
    Cleve Clin J Med; 2010 Oct; 77(10):715-26. PubMed ID: 20889809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications.
    Soupart A; Decaux G
    Clin Nephrol; 1996 Sep; 46(3):149-69. PubMed ID: 8879850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microglia in the pathogenesis of osmotic-induced demyelination.
    Takefuji S; Murase T; Sugimura Y; Takagishi Y; Hayasaka S; Oiso Y; Murata Y
    Exp Neurol; 2007 Mar; 204(1):88-94. PubMed ID: 17126835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms.
    Soupart A; Penninckx R; Stenuit A; Perier O; Decaux G
    J Neuropathol Exp Neurol; 1996 May; 55(5):594-601. PubMed ID: 8627349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in the management of acute and chronic hyponatremia.
    Hoorn EJ; Spasovski G
    Curr Opin Nephrol Hypertens; 2019 Sep; 28(5):424-432. PubMed ID: 31232710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia.
    Abraham WT; Decaux G; Josiassen RC; Yagil Y; Kopyt N; Thacker HP; Mannelli M; Bichet DG; Orlandi C;
    Kidney Int; 2012 Dec; 82(11):1215-22. PubMed ID: 22932122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.